Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

Sabine Hombach-Klonisch¹, Maryam Mehrpour², Shahla Shojaei³, Craig Harlos⁴, Marshall Pitz⁴, Ahmed Hamai², Krzysztof Siemianowicz⁵, Wirginia Likus⁶, Emilia Wiechec⁷, Brian D Toyota⁸, Reyhane Hoshyar⁹, Amir Seyfoori¹⁰, Zahra Sepehri¹¹, Sudharsana R Ande¹², Forough Khadem¹³, Mohsen Akbari¹⁰, Adrienne M Gorman¹⁴, Afshin Samali¹⁴, Thomas Klonisch¹⁵, Saeid Ghavami¹⁶

Affiliations

¹ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
² Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, F-75993 Paris, France; Université Paris Descartes-Sorbonne Paris Cité, F-75012 Paris, France.
³ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Science, Isfahan, Iran.
⁴ Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
⁵ Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
⁶ Department of Anatomy, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
⁷ Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
⁸ Division of Neurosurgery, Department of Surgery, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
⁹ Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran; Department of Clinical Biochemistry, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
¹⁰ Laboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, BC, Canada.
¹¹ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Internal Medicine Department, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran.
¹² Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
¹³ Department of Immunology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
¹⁴ Apoptosis Research Centre, National University of Ireland, Galway, Ireland; School of Natural Sciences, National University of Ireland, Galway, Ireland.
¹⁵ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada. Electronic address: thomas.klonisch@umanitoba.ca.
¹⁶ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Health Policy Research Centre, Shiraz Medical University of Medical Science, Shiraz, Iran. Electronic address: saeid.ghavami@umanitoba.ca.

PMID: 29080702
DOI: 10.1016/j.pharmthera.2017.10.017

Review

Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

Sabine Hombach-Klonisch et al. Pharmacol Ther. 2018 Apr.

. 2018 Apr:184:13-41.

doi: 10.1016/j.pharmthera.2017.10.017. Epub 2017 Nov 8.

Authors

Affiliations

¹ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
² Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, F-75993 Paris, France; Université Paris Descartes-Sorbonne Paris Cité, F-75012 Paris, France.
³ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Science, Isfahan, Iran.
⁴ Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
⁵ Department of Biochemistry, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
⁶ Department of Anatomy, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
⁷ Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
⁸ Division of Neurosurgery, Department of Surgery, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
⁹ Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran; Department of Clinical Biochemistry, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
¹⁰ Laboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, BC, Canada.
¹¹ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Internal Medicine Department, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran.
¹² Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
¹³ Department of Immunology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
¹⁴ Apoptosis Research Centre, National University of Ireland, Galway, Ireland; School of Natural Sciences, National University of Ireland, Galway, Ireland.
¹⁵ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada. Electronic address: thomas.klonisch@umanitoba.ca.
¹⁶ Department of Human Anatomy & Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada; Health Policy Research Centre, Shiraz Medical University of Medical Science, Shiraz, Iran. Electronic address: saeid.ghavami@umanitoba.ca.

PMID: 29080702
DOI: 10.1016/j.pharmthera.2017.10.017

Abstract

Despite advances in neurosurgical techniques and radio-/chemotherapy, the treatment of brain tumors remains a challenge. This is particularly true for the most frequent and fatal adult brain tumor, glioblastoma (GB). Upon diagnosis, the average survival time of GB patients remains only approximately 15months. The alkylating drug temozolomide (TMZ) is routinely used in brain tumor patients and induces apoptosis, autophagy and unfolded protein response (UPR). Here, we review these cellular mechanisms and their contributions to TMZ chemoresistance in brain tumors, with a particular emphasis on TMZ chemoresistance in glioma stem cells and GB.

Keywords: Alkylating drugs; Apoptosis; Autophagy; Bcl-2 family protein; Brain tumor; Cancer therapy; Cell death; DNA repair; Glioblastoma; Glioblastoma stem cells; Temozolomide; Unfolded protein response.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

Affiliations

Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

Authors

Affiliations

Abstract

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical